Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06190236 · ClinicalTrials.gov registry record · NA
Integration of Neurofunctional Phenotyping Into Investigation of CBT4CBT for AUD
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 248
- Enrollment target
NCT06190236 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 248 participants.
The verdict
NCT06190236, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
Study Summary
Alcohol use and misuse are prevalent in the United States. Alcohol use disorder (AUD) is the most common substance use disorder. Evidence-based treatments are effective; however, most people with AUD do not receive treatment, and among those who do, responses to treatment modalities vary. Technology provides the opportunity to expand treatment and improve outcomes. Therefore, the overall goal of this project is to incorporate neurofunctional phenotyping into a preliminary investigation of the feasibility of providing mobile CBT4CBT for AUD among a non-treatment seeking population
Interventions
- BEHAVIORAL Stand-alone web-based cognitive behavioral therapy (CBT4CBT) for alcohol use disorder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2024-04-10 |
| Est. Completion | 2025-04-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06190236
The ClinicalTrials.gov registry entry for NCT06190236 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 248 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stand-alone web-based cognitive behavioral therapy (CBT4CBT) for alcohol use disorder is the first listed.
NCT06190236 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06190236 about?
NCT06190236 is a clinical study titled "Integration of Neurofunctional Phenotyping Into Investigation of CBT4CBT for AUD". Alcohol use and misuse are prevalent in the United States. Alcohol use disorder (AUD) is the most common substance use disorder. Evidence-based treatments are effective; however, most people with AUD do not receive treatment, and among those who do, responses to treatment modalities vary. Technology...
What is the current status of trial NCT06190236?
This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2024-04-10. Estimated completion is 2025-04-22.
What interventions are being tested in trial NCT06190236?
The interventions under investigation include: Stand-alone web-based cognitive behavioral therapy (CBT4CBT) for alcohol use disorder (BEHAVIORAL).
Who is sponsoring clinical trial NCT06190236?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.